Digital Health AI Cardiac Imaging Market Strategy MedTech Sales and Inventory Management Solution Due Diligence Endocrine and GI Disorders Asset Commercial Opportunity Assessment Bioprocessing Reagents Market Sizing and Growth Plan Surgical Robotics Strategic Opportunity Assessment Senior Living Go-To-Market Strategy Enzyme Replacement Therapy Market Assessment CRO Business Development Strategy

Advanced GI Market Strategic Planning Life Science Tools Fundraising Support Radiology Decision Support Tool Go-to-Market Strategy Intraoperative Tumor Visualization Commercial Assessment Biopharma Strategic Partnering Advisory Clinical Trial Supplies and Logistics Landscape Analysis Academic Medical Center 5-year Strategic Plan Brain-Computer Interface Implant Go-to-Market Strategy CRO Business Development Strategy Stroke Aspiration Catheter Market Entry Planning Enteral Feeding Technology Commercial Due Diligence

This deep dive looks at investment trends in precision medicine, the rationale for multicomponent biomarkers for neurological disorders, and examines the potential impact of PM approaches for Alzheimer's disease.

This report provides a review of revenue growth for public companies in FSI’s Life Science Tools and Diagnostics segments from 2019 – 2023 as well as LS Tools and Dx investments and exits: - Revenue performance of public companies in life science tools (including bioprocessing, diversified, and omics-related segments) and diagnostics (including genetic, cancer, and diversified IVD segments) - Overview of VC investments, M&A, and IPOs in LS Tools and Dx - Preview for upcoming Precision Medicine in Neuroscience report

Point-of-Care Molecular Diagnostics GLP-1 Agonists and Cardiac Procedures Digital Health – Specialty Telehealth Bioprocessing Quality Control Clinical Lab Services Health System Innovation Group CRO Services for Biosimilars Development Clinical Research Organization Multi-indication Surgical Robotic Breast Localization and Lymphatic Mapping Pharma Commercialization

Medical Device CMO Commercial Due Diligence Bioprocessing Chromatography Market Forecast Intraoperative Imaging Agent Clinical Development Strategy Digital Health Provider Training Marketing Plan Wireless Breast Lesion Localization Market Landscape Drug Discovery Chromatography Strategic Market Analysis Clinician Training Provider Growth Strategy CRO Strategic Sales

This report highlights company performance in select Cardiovascular (CV) device segments • Revenue performance of key public companies, as well as M&A and investments: Abbott, Boston Scientific, Edwards Lifesciences, J&J, and Medtronic • Overview of VC investments, M&A and IPOs for select segments of interest: Atrial fibrillation, mechanical circulatory support, cardiac monitoring, cardiac rhythm management (CRM), and transcatheter valves

This report highlights analysis and key trends in the Robotic Assisted Surgery (RAS) Landscape. Included are development stage and funding status of RAS platforms in key segments, including surgical platforms and positioning/navigation-enabled platforms, as well as global market size, market trends, and healthcare investments.

This report analyzes revenue growth and investment trends across key Digital Health segments and stakeholders (including Payers, the Big Four Tech and Top MedTech Companies). The Spotlight is Value-based Care, A Digital Health Proving Ground, which highlights how Digital Health can be used to bridge gaps and drive outcomes.

Prostate Biopsy and Mapping Augmented Reality Surgical Navigation  Bioprocessing Quality Control Endoluminal Robotics Academic Medical Center Enteral Feeding Intraoperative Molecular Imaging Medical Device Contract Manufacturing Clinical Research Organization